(Q33637285)

English

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Alzheimer's disease

0 references

florbetapir (18F)

1 reference

based on heuristic

inferred from title

4

object named as

Mark A Mintun

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Charles H Adler

8

object named as

Charles H Adler

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Andrew Siderowf

1

object named as

Andrew Siderowf

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Douglas R. Galasko

9

object named as

Douglas Galasko

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Michael J Pontecorvo

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Holly A Shill

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Anupa Arora

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Abhinay D Joshi

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ming Lu

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Carolyn Liebsack

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Daniel M Skovronsky

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Marwan N Sabbagh

12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

9 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Diagnostic accuracy of ¹²³I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Diagnostic accuracy of dementia with Lewy bodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Diagnostic criteria for Parkinson disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

The early diagnosis of Parkinson's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Cognitive decline is faster in Lewy body variant than in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Core assessment program for intracerebral transplantations (CAPIT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

Neuroleptic sensitivity in patients with senile dementia of Lewy body type

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

“Mini-mental state”

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

The Measurement of Observer Agreement for Categorical Data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027995

28 July 2018

What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

Predicting lewy body pathology in a community-based sample with clinical diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

Imaging beta-amyloid burden in aging and dementia.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-79

21 January 2018

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24716655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/24716655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2377-14-79

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

release_xjgdo3oeqbhwfeo4mcxsjqun2a

1 reference

https://api.fatcat.wiki/v0/release/xjgdo3oeqbhwfeo4mcxsjqun2a

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33637285&oldid=2195598348"